MSCI: RiskMetrics & Mission-Critical Financial Data
Former MD at MSCI
inpractise.com/articles/msci-mission-critical-financial-data
MSCI: RiskMetrics & Mission-Critical Financial Data(July 31, 2025)
Former MD at MSCI
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Yes. I want to own companies that sell critical products needed in both good and bad times, where customers are absolutely reliant on them. My impression is that index products fit that description, but I'm less sure about analytics.
Regarding risk management, depending on where you are in the spectrum of using the product line, whether it's index or analytics, the approach can differ. I'll start with analytics. On the analytics side, some may argue that it's not mission-critical, except in a few situations. However, if you speak to a real risk manager, they might say they won't proceed if the analysis indicates a certain consequence.
This is a snippet of the transcript, sign up to read more.
Related Content
Wolters Kluwer: Enablon & EHS Software
Former Sales Executive at Wolters Kluwer
Moody's: Analytics Product Offering & Customer Perspective
Head of KYC Operations at Digital Bank
Moody's & S&P Global: Private Credit Growth
Former Senior Analyst at Moody's Corp
Moody's Analytics: KYC and AML Solutions
Enterprise Sales Director at Moody’s Corporation
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.